Progyny Inc. (PGNY)
NASDAQ · Healthcare
Progyny Inc. EBITDA 2020–2025
Progyny Inc. annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Progyny Inc. ebitda for the quarter ending March 31, 2026 was 36.9 M, a 45.83% increase year-over-year.
- Progyny Inc. ebitda for the twelve months ending March 31, 2026 was 101.8 M.
- Progyny Inc. annual ebitda for 2025 was 90.2 M, a 27.74% increase from 2024.
- Progyny Inc. annual ebitda for 2024 was 70.6 M, a 9.56% increase from 2023.
- Progyny Inc. annual ebitda for 2023 was 64.5 M, a 158.46% increase from 2022.
- Progyny Inc. annual ebitda for 2022 was 24.9 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Progyny Inc. EBITDA — FAQ
Progyny Inc. (PGNY) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PGNY's ebitda history?
The chart and table above show Progyny Inc.'s ebitda by year and by quarter, including the growth rate.